Edition:
United States

Innovus Pharmaceuticals Inc (INNV.PK)

INNV.PK on OTC Markets Group

0.10USD
22 Sep 2017
Change (% chg)

$-0.00 (-3.15%)
Prev Close
$0.10
Open
$0.09
Day's High
$0.10
Day's Low
$0.09
Volume
677,050
Avg. Vol
470,276
52-wk High
$0.39
52-wk Low
$0.08

Latest Key Developments (Source: Significant Developments)

Innovus Pharmaceuticals Q2 loss per share $0.01
Monday, 14 Aug 2017 04:05pm EDT 

Aug 14 (Reuters) - Innovus Pharmaceuticals Inc :Innovus Pharmaceuticals reports a quarterly net revenue increase of 99.2 percent and net loss decrease of 74.1 percent compared to the same period in 2016.Q2 loss per share $0.01.Q2 revenue $2.0 million versus $1.0 million.  Full Article

Innovus Pharmaceuticals Q1 loss per share $0.02
Friday, 12 May 2017 04:05pm EDT 

May 12 (Reuters) - Innovus Pharmaceuticals Inc ::Innovus Pharmaceuticals reports quarterly revenue for the first quarter 2017 of $2.2 million.Q1 loss per share $0.02.Q1 revenue $2.2 million versus $200,000.Innovus Pharmaceuticals inc- cash balance totaled $2.4 million at march 31, 2017.  Full Article

Innovus Pharma sees FY 2016 revenue $5 million
Friday, 18 Nov 2016 06:00am EST 

Innovus Pharmaceuticals Inc : Innovus Pharma continues to execute with record Q3 '16 revenue -- SECfilings.com . Q3 revenue rose 947 percent to $1.9 million . Sees FY 2016 revenue $5.0 million .Sees FY 2017 revenue $15 million.  Full Article

Innovus Pharmaceuticals Q3 loss per share $0.04
Thursday, 10 Nov 2016 04:01pm EST 

Innovus Pharmaceuticals Inc : Innovus pharma reports record quarterly revenues for the third quarter of 2016, increasing 947% to $1.9 million, and record nine months ended september 2016 revenues, increasing 463% to $3.1 million . Q3 loss per share $0.04 . Sees fy 2016 revenue $5.0 million .Q3 revenue rose 947 percent to $1.9 million.  Full Article

Innovus Pharma Q1 loss per share $0.02
Friday, 20 May 2016 06:10am EDT 

Innovus Pharmaceuticals Inc : Innovus Pharma CEO provides shareholder update and conference call .Q1 loss per share $0.02.  Full Article

BRIEF-Innovus Pharmaceuticals Q2 loss per share $0.01

* Innovus Pharmaceuticals reports a quarterly net revenue increase of 99.2 percent and net loss decrease of 74.1 percent compared to the same period in 2016